|
21 |
A genomic exploration identifies mechanisms that may explain adverse cardiovascular effects of COX-2 inhibitors
Enthalten in Scientific reports Bd. 7, 31.8.2017, Nr. 1, date:12.2017: 1-9
|
|
|
|
22 |
Abstracts from the 8th International Conference on cGMP Generators, Effectors and Therapeutic Implications
Enthalten in BMC pharmacology & toxicology Bd. 18, 10.10.2017, Nr. 1, date:10.2017: 1-35
|
|
|
|
23 |
Analysis of predicted loss-of-function variants in UK Biobank identifies variants protective for disease
Enthalten in Nature Communications Bd. 9, 24.4.2018, Nr. 1, date:12.2018: 1-8
|
|
|
|
24 |
Assessing the causal association of glycine with risk of cardio-metabolic diseases
Enthalten in Nature Communications Bd. 10, 5.3.2019, Nr. 1, date:12.2019: 1-13
|
|
|
|
25 |
Association of angiotensin-converting enzyme 2 (ACE2) gene polymorphisms with parameters of left ventricular hypertrophy in men
Enthalten in Journal of molecular medicine Bd. 84, 11.11.2005, Nr. 1, date:1.2006: 88-96
|
|
|
|
26 |
Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants
Enthalten in Nature genetics Bd. 54, 6.12.2022, Nr. 12, date:12.2022: 1803-1815
|
|
|
|
27 |
Etidronate prevents dystrophic cardiac calcification by inhibiting macrophage aggregation
Enthalten in Scientific reports Bd. 8, 11.4.2018, Nr. 1, date:12.2018: 1-13
|
|
|
|
28 |
Functional evaluation of GUCY1A3 mutations associated with myocardial infarction risk
Enthalten in BMC pharmacology & toxicology Bd. 16, 2.9.2015, Nr. 1, date:12.2015: 1-2
|
|
|
|
29 |
Genetic basis of myocardial infarction: Novel insights from genome-wide association studies
Enthalten in Current Cardiovascular Risk reports Bd. 3, 6.11.2009, Nr. 6, date:11.2009: 426-433
|
|
|
|
30 |
Genetic insights into resting heart rate and its role in cardiovascular disease
Enthalten in Nature Communications Bd. 14, 2.8.2023, Nr. 1, date:12.2023: 1-21
|
|
Administration
